key: cord-0798459-8ur7vmo3
authors: Baj, Andreina; Novazzi, Federica; Genoni, Angelo; Ferrante, Francesca Drago; Taborelli, Stefano; Pini, Beatrice; Partenope, Michele; Valli, Marilena; Gasperina, Daniela Dalla; Capuano, Riccardo; Prestia, Martina; Spezia, Pietro Giorgio; Azzi, Lorenzo; Focosi, Daniele; Maggi, Fabrizio
title: Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution
date: 2021-06-22
journal: Emerging microbes & infections
DOI: 10.1080/22221751.2021.1942230
sha: d64f47d04c2d349fb7f15e8f6e3025641980b96c
doc_id: 798459
cord_uid: 8ur7vmo3

We report 11 cases of SARS-CoV-2 infection in healthcare workers (HCW) naïve for COVID-19 and seropositive after the second dose of the BNT162b2 mRNA vaccine. Based on voluntary-based surveillance, they tested positive for different strains of SARS-CoV-2, as Spike gene sequencing showed. Five of them reported mild symptoms. Given the risk for SARS-CoV-2 introduction from asymptomatic vaccinees, this case series suggests the need to continue nasopharyngeal screening programmes.

Dear Editor, the immune response to the COVID-19 vaccine is typically established by measuring anti-SARS-CoV-2 Spike or anti-RBD IgG in serum, even if no information about IgA levels in respiratory secretions or saliva is available. Playing a pivotal role to prevent SARS-CoV-2 infection and transmission, this has obvious implications for the final reach of herd immunity.

In Italy and many European countries, vaccination campaigns have been started in December 2020 with the BNT162b2 mRNA vaccine Comirnaty® (Pfizer/BioNtech), prioritizing healthcare workers (HCW). The susceptibility of vaccinated HCW to active, albeit asymptomatic, infection is of high interest given the risk of transmitting the virus to frail hospitalized patients. Additionally, the asymptomatic status in the vaccinated HCW could delay recognition of the index case, favouring nosocomial outbreaks.

We report here 11 HCW (mean age: 50±10 years, 3 male and 8 female) who tested positive for SARS-CoV-2 (m2000, Abbott Molecular, Des Plaines, IL), with a mean cycle threshold (Ct) of 19 (range Ct: 6-26) in nasopharyngeal swabs (NPS) after a variable period from the second dose of vaccine (mean days: 43±10).

They were part of voluntary-based surveillance, according to the guidelines of the Italian National Institute of Health and Ministry of Health and Local Ethical Committee (protocol n°165/2020). All of them were naïve to COVID-19 and had successfully mounted anti-Spike serum IgG (LIAISON® SARS-CoV-2 S1/S2 IgG, DiaSorin, Saluggia, Italy) after full schedule vaccination, with a mean antibody titer of 214±99 arbitrary units (AU) for ml. While most cases were asymptomatic for the entire time between the first positive and the first negative NPS, 5 reported fever and arthralgia. Among them, cases #9 and #11 are notable because of positivity in rectal swab. Given the ECDC and Italian Ministry of Health recommendation to sequence SARS-CoV-2 isolated from vaccinees to detect immune-escaping variants of concern [1], we sequenced the entire Spike gene in all 11 cases. Sequences were deposited on GenBank and characterized using NextClade (https://clades. nextstrain.org/), showing the synchronous circulation of different SARS-CoV-2 strains in the Lombardy region. Table 1 summarized the laboratory findings in these cases.

Nevertheless the documented efficacy of BNT162b2 mRNA vaccine (7), at least one case of asymptomatic infection in a vaccinated HCW has been recently reported [2] , but since the biological samples were limited to NPS, it could not be concluded whether the infection had been contained on the nasopharynx or not. Our series is the first to demonstrate that in fully vaccinated HCW, SARS-CoV-2 is not only able to colonize the nasopharynx, but also to infect cells in distant tissues and give clinical symptoms. No case of nosocomial transmission from the HCW described in this series to inpatients has been documented to date, even if the low Ct found is a suggestion of a viable and transmissible virus. While we cannot conclude whether the detected viral RNA was immunocomplexed or not, it is well known that sterilizing immunity against respiratory viruses largely depends on neutralizing IgA levels in secretions. Unfortunately, the intramuscular route of the currently approved vaccines only induces lowlevel IgA in secretions in a minority of recipients [3] [4] [5] .

No potential conflict of interest was reported by the author(s).

Andreina Baj http://orcid.org/0000-0003-0088-2712

European Centre for Disease Prevention and Control. Sequencing of SARS-CoV-2: first update

Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva

The BioNTech / Pfizer vaccine BNT162b2 induces classswitched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization

European Centre for Disease Prevention and Control. Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination